Zornitza Stark

2 months ago | nature.com | Lin Cheng |Zornitza Stark

AbstractTo identify and develop complementary implementation strategies that support nephrologists in mainstreaming renal genomic testing. Interviews were conducted with individuals nominated as ‘genomics champions’ and ‘embedded genomics experts’ as part of a mainstreaming project to identify initial barriers and investigate empirical strategies for delivering the project at initial stage. Data were mapped onto implementation science framework to identify complementary theoretical strategies.

Oct 7, 2024 | nature.com | Zornitza Stark |David Glazer |Oliver Hofmann |Augusto Rendon |Christian R Marshall |Naomi E Allen | +1 more

AbstractGenomic data from millions of individuals have been generated worldwide to drive discovery and clinical impact in precision medicine. Lowering the barriers to using these data collectively is needed to equitably realize the benefits of the diversity and scale of population data.

Nov 13, 2023 | scientificamerican.com | Zornitza Stark |Richard Scott

Should all babies have their genomes sequenced at birth? The question has been hotly debated for the past 15 years. Unlocking the genome’s 3.2-billion-letter code promises understanding of both health and disease. But practical and ethical challenges loom large. We are now at a critical juncture. Multiple genomic newborn screening studies are launching worldwide—with cohort sizes ranging from 1,000 to 100,000 babies.

Nov 13, 2023 | go.nature.com | Zornitza Stark |Richard Scott

Should all babies have their genomes sequenced at birth? The question has been hotly debated for the past 15 years. Unlocking the genome’s 3.2-billion-letter code promises understanding of both health and disease. But practical and ethical challenges loom large. We are now at a critical juncture. Multiple genomic newborn screening studies are launching worldwide—with cohort sizes ranging from 1,000 to 100,000 babies.

Jun 29, 2023 | nature.com | Zornitza Stark |Richard Scott

AbstractRare diseases are a leading cause of infant mortality and lifelong disability. To improve outcomes, timely diagnosis and effective treatments are needed. Genomic sequencing has transformed the traditional diagnostic process, providing rapid, accurate and cost-effective genetic diagnoses to many.